Roberto Di Maio

Also affiliated with Institute for Neurodegenerative Disorders

MedicineNeuroscienceBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “NADPH oxidase 2 activity in Parkinson's disease”.

NADPH oxidase 2 activity in Parkinson's disease

Neurobiology of Disease(2022)10.1016/j.nbd.2022.105754

N/A

0.596DataRank · unranked

52 citations

Eric K. Hoffman, Kyle Farmer, Christopher Bodle, Marco Fazzari, Alevtina Zharikov +11 more

NADPH oxidase 2 activity disrupts Calmodulin/CaMKIIα complex via redox modifications of CaMKIIα-contained Cys30 and Cys289: Implications in Parkinson's disease

Redox Biology(2024)10.1016/j.redox.2024.103254

N/A

0.396DataRank · unranked

13 citations

Madison C. Forsmann, Ignacio J. General, Joseph C. Ayoob, Emily C. Furbee, Sandra L. Castro +4 more

Neuroprotective actions of a fatty acid nitroalkene in Parkinson’s disease.

Research Square(2022)10.21203/rs.3.rs-2367066/v1

N/A

0.104DataRank · unranked

1 citations

Roberto Di Maio, Matthew T. Keeney, Veronika Cechova, Amanda Mortimer, Pascal Rowart +3 more

Neuronal NADPH oxidase 2 in Parkinson’s disease pathogenesis

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.05.13.443999

N/A

0DataRank · unranked

0 citations

Eric K. Hoffman, Kyle Farmer, Christopher R. Bodle, Marco Fazzari, Alevtina Zharikov +9 more

Neuroprotective actions of a fatty acid nitroalkene in Parkinson’s disease

npj Parkinson s Disease(2023)10.1038/s41531-023-00502-3

N/A

0DataRank · unranked

15 citations

Matthew T. Keeney, Veronika Cechova, Amanda Mortimer, Ahssan Sekandari, Pascal Rowart +4 more